- Home
- NMZ vs IMTX Comparison
NMZ vs IMTX Comparison
Compare NMZ & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NMZ | IMTX |
|---|---|---|
| Founded | 2003 | N/A |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.3B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | NMZ | IMTX |
|---|---|---|
| Price | $10.42 | $10.02 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $19.25 |
| AVG Volume (30 Days) | 356.8K | ★ 590.7K |
| Earning Date | 01-01-0001 | 11-17-2025 |
| Dividend Yield | ★ 5.08% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $99,445,031.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $24.39 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $8.26 | $3.30 |
| 52 Week High | $11.14 | $12.41 |
Technical Indicators
Market Signals| Indicator | NMZ | IMTX |
|---|---|---|
| Relative Strength Index (RSI) | 34.27 | 48.35 |
| Support Level | $10.51 | $9.86 |
| Resistance Level | $10.60 | $12.41 |
| Average True Range (ATR) | 0.08 | 0.71 |
| MACD | -0.02 | -0.11 |
| Stochastic Oscillator | 14.81 | 8.27 |
Price Performance
Historical ComparisonAbout NMZ Nuveen Municipal High Income Opportunity Fund $0.01 par value per share
Nuveen Municipal High Income Opp Fund is a diversified, closed-end management investment company. The company's investment objectives is to provide current income exempt from regular federal income tax by investing predominantly in a portfolio of municipal obligations issued by state and local government authorities or certain U.S. territories. It seeks to provide attractive monthly tax-free income, portfolio diversification and attractive after tax total returns. The fund invests in municipal securities that are exempt from federal income taxes.
About IMTX Immatics N.V.
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.